Five potential buyers are currently in the running to acquire MedCath’s 53.4 percent stake in the facility. The names of the five groups have not been publicly disclosed, according to the report.
Read The Bakersfield Californian report on Bakersfield Heart Hospital.
Related Articles on MedCath:
MedCath Seeks Stockholder Approval to Dissolve Company
FTC Approves Sale of MedCath’s Heart Hospital of New Mexico to Lovelace Health
MedCath to Sell Arkansas Heart Hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
